Advertisement

Pain Associated with Radiation Treatment for Breast Cancer

  • Eunkyung Lee
  • Shannon Snyder
  • Jennifer J. HuEmail author
Chapter

Abstract

Breast cancer is the most frequently diagnosed cancer and the second leading cause of cancer death in American women. Postsurgical adjuvant radiotherapy (RT) significantly improves local-regional recurrence and breast cancer survival, so currently most breast cancer patients receive RT after surgery. However, pain related to cancer or treatment is a critical quality of life issue for breast cancer survivors. Most of the previous studies have focused on chemotherapy-related neuropathy; however, many breast cancer patients undergoing RT experience clinically significant levels of unrelieved cancer pain despite standard pain management. Multiple risk factors contribute to pre-RT, post-RT, and RT-related pain. Considering pre-RT pain is an independent risk factor for post-RT pain, and also RT-associated pain can last for many decades, pain management during RT may be an effective preventive strategy. Furthermore, if hypo-fractionation RT can provide equivalent long-term tumor control and survival but with reduced RT-associated pain, it may present a cost-effective treatment strategy to improve RT outcomes. Lastly, compared to non-Hispanic Whites, underserved minorities are more likely to suffer worse RT-related pain. Therefore, future research is warranted to characterize the molecular mechanisms of RT-related pain disparities and identify high-risk population for precision intervention.

Keywords

Breast cancer Radiation treatment Pain management 

References

  1. 1.
    Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.CrossRefPubMedGoogle Scholar
  2. 2.
    Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66(4):271–89.PubMedCrossRefGoogle Scholar
  3. 3.
    International Association for the Study of Pain. IASP terminology. Updated December 14, 2017. Available from: http://www.iasp-pain.org/terminology?navItemNumber=576#Pain.
  4. 4.
    Caraceni A, Portenoy RK. An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain. 1999;82(3):263–74.PubMedCrossRefGoogle Scholar
  5. 5.
    Ishiyama H, Niino K, Hosoya T, Hayakawa K. Results of a questionnaire survey for symptom of late complications caused by radiotherapy in breast conserving therapy. Breast Cancer (Tokyo, Japan). 2006;13(2):197–201.CrossRefGoogle Scholar
  6. 6.
    Whelan TJ, Levine M, Julian J, Kirkbride P, Skingley P. The effects of radiation therapy on quality of life of women with breast carcinoma: results of a randomized trial. Ontario Clinical Oncology Group. Cancer. 2000;88(10):2260–6.PubMedCrossRefGoogle Scholar
  7. 7.
    Gartner R, Jensen MB, Nielsen J, Ewertz M, Kroman N, Kehlet H. Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA. 2009;302(18):1985–92.PubMedCrossRefGoogle Scholar
  8. 8.
    Carpenter JS, Andrykowski MA, Sloan P, Cunningham L, Cordova MJ, Studts JL, et al. Postmastectomy/postlumpectomy pain in breast cancer survivors. J Clin Epidemiol. 1998;51(12):1285–92.PubMedCrossRefGoogle Scholar
  9. 9.
    Chen SC, Lai YH, Liao CT, Lin CC, Chang JT. Changes of symptoms and depression in oral cavity cancer patients receiving radiation therapy. Oral Oncol. 2010;46(7):509–13.PubMedCrossRefGoogle Scholar
  10. 10.
    Mak KS, Chen YH, Catalano PJ, Punglia RS, Wong JS, Truong L, et al. Dosimetric inhomogeneity predicts for long-term breast pain after breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2014;93(5):1087–95.PubMedCrossRefGoogle Scholar
  11. 11.
    Mukherjee D, Coates PJ, Lorimore SA, Wright EG. Responses to ionizing radiation mediated by inflammatory mechanisms. J Pathol. 2014;232(3):289–99.PubMedCrossRefGoogle Scholar
  12. 12.
    Bower JE, Ganz PA, Tao ML, Hu W, Belin TR, Sepah S, et al. Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clin Cancer Res. 2009;15(17):5534–40.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Schaue D, Micewicz ED, Ratikan JA, Xie MW, Cheng G, McBride WH. Radiation and inflammation. Semin Radiat Oncol. 2015;25(1):4–10.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Hekim N, Cetin Z, Nikitaki Z, Cort A, Saygili EI. Radiation triggering immune response and inflammation. Cancer Lett. 2015;368(2):156–63.PubMedCrossRefGoogle Scholar
  15. 15.
    Ki Y, Kim W, Nam J, Kim D, Park D, Kim D. C-reactive protein levels and radiation-induced mucositis in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2009;75(2):393–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Chen MF, Chen WC, Lai CH, Hung CH, Liu KC, Cheng YH. Predictive factors of radiation-induced skin toxicity in breast cancer patients. BMC Cancer. 2010;10:508.PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Rodriguez-Gil JL, Takita C, Wright J, Reis IM, Zhao W, Lally BE, et al. Inflammatory biomarker C-reactive protein and radiotherapy-induced early adverse skin reactions in patients with breast cancer. Cancer Epidemiol Biomarkers Prev. 2014;23(9):1873–83.PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Dropcho EJ. Neurotoxicity of radiation therapy. Neurol Clin. 2010;28(1):217–34.PubMedCrossRefGoogle Scholar
  19. 19.
    Jensen TS, Baron R, Haanpaa M, Kalso E, Loeser JD, Rice AS, et al. A new definition of neuropathic pain. Pain. 2011;152(10):2204–5.PubMedCrossRefGoogle Scholar
  20. 20.
    Saxena AKR, Kumar S. Management strategies for pain in breast carcinoma patients: current opinions and future perspectives. Pain Pract. 2007;7(2):163–77.PubMedCrossRefGoogle Scholar
  21. 21.
    Kurita GP, Sjøgren P. Pain management in cancer survivorship. Acta Oncol. 2015;54(5):629–34.PubMedCrossRefGoogle Scholar
  22. 22.
    Meacham K, Shepherd A, Mohapatra DP, Haroutounian S. Neuropathic pain: central vs. peripheral mechanisms. Curr Pain Headache Rep. 2017;21(6):28.PubMedCrossRefGoogle Scholar
  23. 23.
    Wright JL, Takita C, Reis IM, Zhao W, Lee E, Nelson OL, et al. Prospective evaluation of radiation-induced skin toxicity in a race/ethnically diverse breast cancer population. Cancer Med. 2016;5(3):454–64.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Wright JL, Takita C, Reis IM, Zhao W, Lee E, Hu JJ. Racial variations in radiation-induced skin toxicity severity: data from a prospective cohort receiving postmastectomy radiation. Int J Radiat Oncol Biol Phys. 2014;90(2):335–43.PubMedCrossRefGoogle Scholar
  25. 25.
    Pignol J-P, Thuc Vu TT, Mitera G, Bosnic S, Verkooijen HM, Truong P. Prospective evaluation of severe skin toxicity and pain during postmastectomy radiation therapy. Int J Radiat Oncol Biol Phys. 2015;91(1):157–64.PubMedCrossRefGoogle Scholar
  26. 26.
    Wengström Y, Häggmark C, Strander H, Forsberg C. Perceived symptoms and quality of life in women with breast cancer receiving radiation therapy. Eur J Oncol Nurs. 2000;4(2):78–88.PubMedCrossRefGoogle Scholar
  27. 27.
    Hofsø K, Rustøen T, Cooper BA, Bjordal K, Miaskowski C. Changes over time in occurrence, severity, and distress of common symptoms during and after radiation therapy for breast cancer. J Pain Symptom Manag. 2013;45(6):980–1006.CrossRefGoogle Scholar
  28. 28.
    Stapleton SJ, Valerio TD, Astroth K, Woodhouse S. Distress during radiation therapy: assessment among patients with breast or prostate cancer. Clin J Oncol Nurs. 2017;21(1):93–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Sjövall K, Strömbeck G, Löfgren A, Bendahl PO, Gunnars B. Adjuvant radiotherapy of women with breast cancer – information, support and side-effects. Eur J Oncol Nurs. 2010;14(2):147–53.PubMedCrossRefGoogle Scholar
  30. 30.
    Holli K, Pitkänen M, Järvenpää R, Rajala J, Lahtela S, Hyödynmaa S, et al. Early skin and lung reactions in breast cancer patients after radiotherapy: prospective study. Radiother Oncol. 2002;64(2):163–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Fang P, Tan KS, Troxel AB, Rengan R, Freedman G, Lin LL. High body mass index is associated with worse quality of life in breast cancer patients receiving radiotherapy. Breast Cancer Res Treat. 2013;141(1):125–33.PubMedCrossRefGoogle Scholar
  32. 32.
    Lee E, Takita C, Wright JL, Reis IM, Zhao W, Nelson OL, et al. Characterization of risk factors for adjuvant radiotherapy-associated pain in a tri-racial/ethnic breast cancer population. Pain. 2016;157(5):1122–31.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Schou Bredal I, Smeby NA, Ottesen S, Warncke T, Schlichting E. Chronic pain in breast cancer survivors: comparison of psychosocial, surgical, and medical characteristics between survivors with and without pain. J Pain Symptom Manag. 2014;48(5):852–62.CrossRefGoogle Scholar
  34. 34.
    Hopwood P, Haviland JS, Sumo G, Mills J, Bliss JM, Yarnold JR, et al. Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials. Lancet Oncol. 2010;11(3):231–40.PubMedCrossRefGoogle Scholar
  35. 35.
    Tortorelli G, Di Murro L, Barbarino R, Cicchetti S, di Cristino D, Falco MD, et al. Standard or hypofractionated radiotherapy in the postoperative treatment of breast cancer: a retrospective analysis of acute skin toxicity and dose inhomogeneities. BMC Cancer. 2013;13:230.PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Jagsi R, Griffith KA, Boike TP, Walker E, Nurushev T, Grills IS, et al. Differences in the acute toxic effects of breast radiotherapy by fractionation schedule: comparative analysis of physician-assessed and patient-reported outcomes in a large multicenter cohort. JAMA Oncol. 2015;1(7):918–30.PubMedCrossRefGoogle Scholar
  37. 37.
    Bajrovic A, Rades D, Fehlauer F, Tribius S, Hoeller U, Rudat V, et al. Is there a life-long risk of brachial plexopathy after radiotherapy of supraclavicular lymph nodes in breast cancer patients? Radiother Oncol. 2004;71(3):297–301.PubMedCrossRefGoogle Scholar
  38. 38.
    Johansson S, Svensson H, Larsson L-G, Denekamp J. Brachial plexopathy after postoperative radiotherapy of breast cancer patients: a long-term follow-up. Acta Oncol. 2000;39(3):373–82.PubMedCrossRefGoogle Scholar
  39. 39.
    Lundstedt D, Gustafsson M, Steineck G, Malmstrom P, Alsadius D, Sundberg A, et al. Risk factors of developing long-lasting breast pain after breast cancer radiotherapy. Int J Radiat Oncol Biol Phys. 2012;83(1):71–8.PubMedCrossRefGoogle Scholar
  40. 40.
    Gotoda Y, Kambara N, Sakai T, Kishi Y, Kodama K, Koyama T. The morbidity, time course and predictive factors for persistent post-thoracotomy pain. Eur J Pain (London, England). 2001;5(1):89–96.CrossRefGoogle Scholar
  41. 41.
    Sipila R, Estlander AM, Tasmuth T, Kataja M, Kalso E. Development of a screening instrument for risk factors of persistent pain after breast cancer surgery. Br J Cancer. 2012;107(9):1459–66.PubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    Hauser W, Schmutzer G, Hilbert A, Brahler E, Henningsen P. Prevalence of chronic disabling noncancer pain and associated demographic and medical variables: a cross-sectional survey in the general German population. Clin J Pain. 2015;31(10):886–92.PubMedCrossRefGoogle Scholar
  43. 43.
    Fecho K, Miller NR, Merritt SA, Klauber-Demore N, Hultman CS, Blau WS. Acute and persistent postoperative pain after breast surgery. Pain Med. 2009;10(4):708–15.PubMedCrossRefGoogle Scholar
  44. 44.
    Goodson NJ, Smith BH, Hocking LJ, McGilchrist MM, Dominiczak AF, Morris A, et al. Cardiovascular risk factors associated with the metabolic syndrome are more prevalent in people reporting chronic pain: results from a cross-sectional general population study. Pain. 2013;154(9):1595–602.PubMedCrossRefGoogle Scholar
  45. 45.
    Rossi HL, Luu AK, DeVilbiss JL, Recober A. Obesity increases nociceptive activation of the trigeminal system. Eur J Pain (London, England). 2013;17(5):649–53.CrossRefGoogle Scholar
  46. 46.
    Wedin S, Byrne K, Morgan K, Lepage M, Goldman R, Crowley N, et al. Presurgical weight is associated with pain, functional impairment, and anxiety among gastric bypass surgery patients. Pain Res Treat. 2012;2012:412174.PubMedPubMedCentralGoogle Scholar
  47. 47.
    Briggs MS, Givens DL, Schmitt LC, Taylor CA. Relations of C-reactive protein and obesity to the prevalence and the odds of reporting low back pain. Arch Phys Med Rehabil. 2013;94(4):745–52.PubMedCrossRefGoogle Scholar
  48. 48.
    Vissers PA, Thong MS, Pouwer F, Zanders MM, Coebergh JW, van de Poll-Franse LV. The impact of comorbidity on Health-Related Quality of Life among cancer survivors: analyses of data from the PROFILES registry. J Cancer Survivorship Res Pract. 2013;7(4):602–13.CrossRefGoogle Scholar
  49. 49.
    Yi J, Zheng JY, Zhang W, Wang S, Yang ZF, Dou KF. Decreased pain threshold and enhanced synaptic transmission in the anterior cingulate cortex of experimental hypothyroidism mice. Mol Pain. 2014;10:38.PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Rahim-Williams FB, Riley JL 3rd, Herrera D, Campbell CM, Hastie BA, Fillingim RB. Ethnic identity predicts experimental pain sensitivity in African Americans and Hispanics. Pain. 2007;129(1–2):177–84.PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Martinez KA, Snyder CF, Malin JL, Dy SM. Is race/ethnicity related to the presence or severity of pain in colorectal and lung cancer? J Pain Symptom Manag. 2014;48:1050–9.CrossRefGoogle Scholar
  52. 52.
    McCann B, Miaskowski C, Koetters T, Baggott C, West C, Levine JD, et al. Associations between pro- and anti-inflammatory cytokine genes and breast pain in women prior to breast cancer surgery. J Pain Off J Am Pain Soc. 2012;13(5):425–37.CrossRefGoogle Scholar
  53. 53.
    Stephens K, Cooper BA, West C, Paul SM, Baggott CR, Merriman JD, et al. Associations between cytokine gene variations and severe persistent breast pain in women following breast cancer surgery. J Pain Off J Am Pain Soc. 2014;15(2):169–80.CrossRefGoogle Scholar
  54. 54.
    Caronia D, Martin M, Sastre J, de la Torre J, Garcia-Saenz JA, Alonso MR, et al. A polymorphism in the cytidine deaminase promoter predicts severe capecitabine-induced hand-foot syndrome. Clin Cancer Res Off J Am Assoc Cancer Res. 2011;17(7):2006–13.CrossRefGoogle Scholar
  55. 55.
    Garcia-Giralt N, Rodriguez-Sanz M, Prieto-Alhambra D, Servitja S, Torres-Del Pliego E, Balcells S, et al. Genetic determinants of aromatase inhibitor-related arthralgia: the B-ABLE cohort study. Breast Cancer Res Treat. 2013;140(2):385–95.PubMedCrossRefGoogle Scholar
  56. 56.
    Reyes-Gibby CC, Wang J, Silvas MR, Yu RK, Hanna EY, Shete S. Genome-wide association study suggests common variants within RP11-634B7.4 gene influencing severe pre-treatment pain in head and neck cancer patients. Sci Rep. 2016;6:34206.PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Benbernou N, Esnault S, Galibert F. Activation of SRE and AP1 by olfactory receptors via the MAPK and Rho dependent pathways. Cell Signal. 2013;25(6):1486–97.PubMedCrossRefGoogle Scholar
  58. 58.
    Reyes-Gibby CC, Wang J, Silvas MR, Yu R, Yeung SC, Shete S. MAPK1/ERK2 as novel target genes for pain in head and neck cancer patients. BMC Genet. 2016;17:40.PubMedPubMedCentralCrossRefGoogle Scholar
  59. 59.
    Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, et al. A classification of chronic pain for ICD-11. Pain. 2015;156(6):1003–7.PubMedPubMedCentralGoogle Scholar
  60. 60.
    Jackson T, Thomas S, Stabile V, Shotwell M, Han X, McQueen K. A systematic review and meta-analysis of the global burden of chronic pain without clear etiology in low- and middle-income countries: trends in heterogeneous data and a proposal for new assessment methods. Anesth Analg. 2016;123(3):739–48.PubMedCrossRefGoogle Scholar
  61. 61.
    Andersen KG, Jensen MB, Kehlet H, Gartner R, Eckhoff L, Kroman N. Persistent pain, sensory disturbances and functional impairment after adjuvant chemotherapy for breast cancer: cyclophosphamide, epirubicin and fluorouracil compared with docetaxel + epirubicin and cyclophosphamide. Acta Oncol. 2012;51(8):1036–44.PubMedCrossRefGoogle Scholar
  62. 62.
    Peuckmann V, Ekholm O, Rasmussen NK, Groenvold M, Christiansen P, Moller S, et al. Chronic pain and other sequelae in long-term breast cancer survivors: nationwide survey in Denmark. Eur J Pain (London, England). 2009;13(5):478–85.CrossRefGoogle Scholar
  63. 63.
    Lundstedt D, Gustafsson M, Malmstrom P, Johansson KA, Alsadius D, Sundberg A, et al. Symptoms 10-17 years after breast cancer radiotherapy data from the randomised SWEBCG91-RT trial. Radiotherapy and oncology: journal of the European Society for Therapeutic. Radiol Oncol. 2010;97(2):281–7.CrossRefGoogle Scholar
  64. 64.
    van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007;18(9):1437–49.PubMedCrossRefGoogle Scholar
  65. 65.
    Tasmuth T, von Smitten K, Hietanen P, Kataja M, Kalso E. Pain and other symptoms after different treatment modalities of breast cancer. Ann Oncol. 1995;6(5):453–9.PubMedCrossRefGoogle Scholar
  66. 66.
    Jud SM, Fasching PA, Maihöfner C, Heusinger K, Loehberg CR, Hatko R, et al. Pain perception and detailed visual pain mapping in breast cancer survivors. Breast Cancer Res Treat. 2009;119(1):105.PubMedCrossRefGoogle Scholar
  67. 67.
    Andersen KG, Kehlet H. Persistent pain after breast cancer treatment: a critical review of risk factors and strategies for prevention. J Pain Off J Am Pain Soc. 2011;12(7):725–46.CrossRefGoogle Scholar
  68. 68.
    Wang L, Guyatt GH, Kennedy SA, Romerosa B, Kwon HY, Kaushal A, et al. Predictors of persistent pain after breast cancer surgery: a systematic review and meta-analysis of observational studies. CMAJ Can Med Assoc J. 2016;188(14):E352–E61.CrossRefGoogle Scholar
  69. 69.
    Midttun M, Sejrsen P, Paaske WP. Smokers have severely disturbed peripheral micro-circulation. Int Angiol J Int Union Angiol. 2006;25(3):293–6.Google Scholar
  70. 70.
    Delanian S, Lefaix J-L, Pradat P-F. Radiation-induced neuropathy in cancer survivors. Radiother Oncol. 2012;105(3):273–82.PubMedCrossRefGoogle Scholar
  71. 71.
    Gosk J, Rutowski R, Reichert P, Rabczyński J. Review article: radiation-induced brachial plexus neuropathy – aetiopathogenesis, risk factors, differential diagnostics, symptoms and treatment. Folia Neuropathol. 2007;45(1):26–30.PubMedGoogle Scholar
  72. 72.
    Wu SG, Huang SJ, Zhou J, Sun JY, Guo H, Li FY, et al. Dosimetric analysis of the brachial plexus among patients with breast cancer treated with post-mastectomy radiotherapy to the ipsilateral supraclavicular area: report of 3 cases of radiation-induced brachial plexus neuropathy. Radiat Oncol. 2014;9:292.PubMedPubMedCentralCrossRefGoogle Scholar
  73. 73.
    Fathers E, Thrush D, Huson SM, Norman A. Radiation-induced brachial plexopathy in women treated for carcinoma of the breast. Clin Rehabil. 2002;16(2):160–5.PubMedCrossRefGoogle Scholar
  74. 74.
    Thyagarajan D, Cascino T, Harms G. Magnetic resonance imaging in brachial plexopathy of cancer. Neurology. 1995;45(3 Pt 1):421–7.PubMedCrossRefGoogle Scholar
  75. 75.
    Olsen NK, Pfeiffer P, Johannsen L, Schrøder H, Rose C. Radiation-induced brachial plexopathy: neurological follow-up in 161 recurrence-free breast cancer patients. Int J Radiat Oncol Biol Phys. 1993;26(1):43–9.PubMedCrossRefGoogle Scholar
  76. 76.
    Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21(1):109–22.PubMedCrossRefGoogle Scholar
  77. 77.
    Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, et al. American Cancer Society/American Society of Clinical Oncology breast cancer survivorship care guideline. J Clin Oncol. 2016;34(6):611–35.PubMedCrossRefGoogle Scholar
  78. 78.
    World Health Organization. Cancer pain relief with a guide to opioid availability. 2nd ed. Geneva: World Health Organization; 1996.Google Scholar
  79. 79.
    Gerbershagen HJ, Rothaug J, Kalkman CJ, Meissner W. Determination of moderate-to-severe postoperative pain on the numeric rating scale: a cut-off point analysis applying four different methods. Br J Anaesth. 2011;107(4):619–26.PubMedCrossRefGoogle Scholar
  80. 80.
    National Comprehensive Cancer Network. NCCN guidelines: adult cancer pain. Version 2. Fort Washington: National Comprehensive Cancer Network; 2015.. 2015 [updated 05/18/2015; cited 2015 Aug 18]. Available from: http://www.nccn.org/professionals/physician_gls/pdf/pain.pdfGoogle Scholar
  81. 81.
    Mejdahl MK, Andersen KG, Gartner R, Kroman N, Kehlet H. Persistent pain and sensory disturbances after treatment for breast cancer: six year nationwide follow-up study. BMJ. 2013;346:f1865.PubMedCrossRefGoogle Scholar
  82. 82.
    Hoeller U, Bonacker M, Bajrovic A, Alberti W, Adam G. Radiation-induced plexopathy and fibrosis. Is magnetic resonance imaging the adequate diagnostic tool? Strahlenther Onkol Organ Dtschen Rontgengesellschaft [et al]. 2004;180(10):650–4.Google Scholar
  83. 83.
    Nich C, Bonnin P, Laredo JD, Sedel L. An uncommon form of delayed radio-induced brachial plexopathy. Chir Main. 2005;24(1):48–51.PubMedCrossRefGoogle Scholar
  84. 84.
    Jaeckle KA. Neurologic manifestations of neoplastic and radiation-induced plexopathies. Semin Neurol. 2010;30(3):254–62.PubMedCrossRefGoogle Scholar
  85. 85.
    Ventafridda V, Tamburini M, Caraceni A, De Conno F, Naldi F. A validation study of the WHO method for cancer pain relief. Cancer. 1987;59(4):850–6.PubMedCrossRefGoogle Scholar
  86. 86.
    Zech DF, Grond S, Lynch J, Hertel D, Lehmann KA. Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain. 1995;63(1):65–76.PubMedCrossRefGoogle Scholar
  87. 87.
    Sloan PA. The evolving role of interventional pain management in oncology. J Support Oncol. 2004;2(6):491–500.. 3PubMedGoogle Scholar
  88. 88.
    Syrjala KL, Jensen MP, Mendoza ME, Yi JC, Fisher HM, Keefe FJ. Psychological and behavioral approaches to cancer pain management. J Clin Oncol Off J Am Soc Clin Oncol. 2014;32(16):1703–11.CrossRefGoogle Scholar
  89. 89.
    Lossignol DA. Psychological interventions to reduce pain in patients with cancer. Curr Opin Oncol. 2013;25(4):368–72.PubMedGoogle Scholar
  90. 90.
    Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Friedman DL, et al. Survivorship: pain version 1.2014. J Natl Compr Cancer Netw (JNCCN). 2014;12(4):488–500.CrossRefGoogle Scholar
  91. 91.
    Chilcot J, Norton S, Hunter MS. Cognitive behaviour therapy for menopausal symptoms following breast cancer treatment: who benefits and how does it work? Maturitas. 2014;78(1):56–61.PubMedCrossRefGoogle Scholar
  92. 92.
    Johannsen M, O’Connor M, O’Toole MS, Jensen AB, Højris I, Zachariae R. Efficacy of mindfulness-based cognitive therapy on late post-treatment pain in women treated for primary breast cancer: a randomized controlled trial. J Clin Oncol. 2016;34(28):3390–9.PubMedCrossRefGoogle Scholar
  93. 93.
    Johannsen M, Farver I, Beck N, Zachariae R. The efficacy of psychosocial intervention for pain in breast cancer patients and survivors: a systematic review and meta-analysis. Breast Cancer Res Treat. 2013;138(3):675–90.PubMedCrossRefGoogle Scholar
  94. 94.
    Tatrow K, Montgomery GH. Cognitive behavioral therapy techniques for distress and pain in breast cancer patients: a meta-analysis. J Behav Med. 2006;29(1):17–27.PubMedCrossRefGoogle Scholar
  95. 95.
    Clubb B. Management of neuropathic pain following treatment for breast cancer in the absence of recurrence: a challenge for the radiation oncologist. Australas Radiol. 2004;48(4):459–65.PubMedCrossRefGoogle Scholar
  96. 96.
    Jung BF, Herrmann D, Griggs J, Oaklander AL, Dworkin RH. Neuropathic pain associated with non-surgical treatment of breast cancer. Pain. 2005;118(1):10–4.PubMedCrossRefGoogle Scholar
  97. 97.
    Dworkin RH, Backonja M, Rowbotham MC, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol. 2003;60(11):1524–34.PubMedCrossRefGoogle Scholar
  98. 98.
    Dubinsky RM, Kabbani H, El-Chami Z, Boutwell C, Ali H. Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2004;63(6):959–65.PubMedCrossRefGoogle Scholar
  99. 99.
    Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain. 2005;116(1–2):109–18.PubMedCrossRefGoogle Scholar
  100. 100.
    Gallagher HC, Gallagher RM, Butler M, Buggy DJ, Henman MC. Venlafaxine for neuropathic pain in adults. Cochrane Database Syst Rev. 2015;8:CD011091.Google Scholar
  101. 101.
    Hammack JE, Michalak JC, Loprinzi CL, Sloan JA, Novotny PJ, Soori GS, et al. Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy. Pain. 2002;98(1–2):195–203.PubMedCrossRefGoogle Scholar
  102. 102.
    Kim J, Park HS, Cho SY, Baik HJ, Kim JH. The effect of stellate ganglion block on intractable lymphedema after breast cancer surgery. Kor J Pain. 2015;28(1):61–3.CrossRefGoogle Scholar
  103. 103.
    Nabil Abbas D, Abd El Ghafar EM, Ibrahim WA, Omran AF. Fluoroscopic stellate ganglion block for postmastectomy pain: a comparison of the classic anterior approach and the oblique approach. Clin J Pain. 2011;27(3):207–13.PubMedCrossRefGoogle Scholar
  104. 104.
    Satija A, Ahmed S, Gupta R, Ahmed A, Rana SP, Singh S, et al. Breast cancer pain management – a review of current & novel therapies. Indian J Med Res. 2014;139(2):216–25.PubMedPubMedCentralGoogle Scholar
  105. 105.
    Teixeira MJ, Fonoff ET, Montenegro MC. Dorsal root entry zone lesions for treatment of pain-related to radiation-induced plexopathy. Spine. 2007;32(10):E316–9.PubMedCrossRefGoogle Scholar
  106. 106.
    Soto O. Radiation-induced conduction block: resolution following anticoagulant therapy. Muscle Nerve. 2005;31(5):642–5.PubMedCrossRefGoogle Scholar
  107. 107.
    Glantz MJ, Burger PC, Friedman AH, Radtke RA, Massey EW, Schold SC Jr. Treatment of radiation-induced nervous system injury with heparin and warfarin. Neurology. 1994;44(11):2020–7.PubMedCrossRefGoogle Scholar
  108. 108.
    Carl UM, Feldmeier JJ, Schmitt G, Hartmann KA. Hyperbaric oxygen therapy for late sequelae in women receiving radiation after breast-conserving surgery. Int J Radiat Oncol Biol Phys. 2001;49(4):1029–31.PubMedCrossRefGoogle Scholar
  109. 109.
    Pritchard J, Anand P, Broome J, Davis C, Gothard L, Hall E, et al. Double-blind randomized phase II study of hyperbaric oxygen in patients with radiation-induced brachial plexopathy. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2001;58(3):279–86.CrossRefGoogle Scholar
  110. 110.
    Delanian S, Lefaix JL. Current management for late normal tissue injury: radiation-induced fibrosis and necrosis. Semin Radiat Oncol. 2007;17(2):99–107.PubMedCrossRefGoogle Scholar
  111. 111.
    Bennett MH, Feldmeier J, Hampson NB, Smee R, Milross C. Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database Syst Rev. 2016;4:Cd005005.PubMedGoogle Scholar
  112. 112.
    Teguh DN, Bol Raap R, Struikmans H, Verhoef C, Koppert LB, Koole A, et al. Hyperbaric oxygen therapy for late radiation-induced tissue toxicity: prospectively patient-reported outcome measures in breast cancer patients. Radiat Oncol (London, England). 2016;11:130.CrossRefGoogle Scholar
  113. 113.
    Okunieff P, Augustine E, Hicks JE, Cornelison TL, Altemus RM, Naydich BG, et al. Pentoxifylline in the treatment of radiation-induced fibrosis. J Clin Oncol. 2004;22(11):2207–13.PubMedCrossRefGoogle Scholar
  114. 114.
    Williamson R, Kondziolka D, Kanaan H, Lunsford LD, Flickinger JC. Adverse radiation effects after radiosurgery may benefit from oral vitamin E and pentoxifylline therapy: a pilot study. Stereotact Funct Neurosurg. 2008;86(6):359–66.PubMedCrossRefGoogle Scholar
  115. 115.
    Gothard L, Cornes P, Brooker S, Earl J, Glees J, Hall E, et al. Phase II study of vitamin E and pentoxifylline in patients with late side effects of pelvic radiotherapy. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2005;75(3):334–41.CrossRefGoogle Scholar
  116. 116.
    Pradat PF, Maisonobe T, Psimaras D, Lenglet T, Porcher R, Lefaix JL, et al. Radiation-induced neuropathies: collateral damage of improved cancer prognosis. Rev Neurol. 2012;168(12):939–50.PubMedCrossRefGoogle Scholar
  117. 117.
    Simone CB 2nd, Vapiwala N, Hampshire MK, Metz JM. Cancer patient attitudes toward analgesic usage and pain intervention. Clin J Pain. 2012;28(2):157–62.PubMedPubMedCentralCrossRefGoogle Scholar
  118. 118.
    Andersen KG, Duriaud HM, Jensen HE, Kroman N, Kehlet H. Predictive factors for the development of persistent pain after breast cancer surgery. Pain. 2015;156(12):2413–22.PubMedCrossRefGoogle Scholar
  119. 119.
    Belfer I, Schreiber KL, Shaffer JR, Shnol H, Blaney K, Morando A, et al. Persistent postmastectomy pain in breast cancer survivors: analysis of clinical, demographic, and psychosocial factors. J Pain Off J Am Pain Soc. 2013;14(10):1185–95.CrossRefGoogle Scholar
  120. 120.
    Lundstedt D, Gustafsson M, Steineck G, Malmström P, Alsadius D, Sundberg A, et al. Risk factors of developing long-lasting breast pain after breast cancer radiotherapy. Int J Radiat Oncol Biol Phys. 2012;83(1):71–8.PubMedCrossRefGoogle Scholar
  121. 121.
    Johansson S, Svensson H, Denekamp J. Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients. Int J Radiat Oncol Biol Phys. 2000;48(3):745–50.PubMedCrossRefGoogle Scholar
  122. 122.
    Johansson S, Svensson H, Denekamp J. Dose response and latency for radiation-induced fibrosis, edema, and neuropathy in breast cancer patients. Int J Radiat Oncol Biol Phys. 2002;52(5):1207–19.PubMedCrossRefGoogle Scholar
  123. 123.
    Friberg S, Ruden BI. Hypofractionation in radiotherapy. An investigation of injured Swedish women, treated for cancer of the breast. Acta Oncol. 2009;48(6):822–31.PubMedCrossRefGoogle Scholar
  124. 124.
    Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, Parpia S, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362(6):513–20.PubMedCrossRefGoogle Scholar
  125. 125.
    Frampton CL, Hughes-Webb P. The measurement of pain. Clin Oncol. 2011;23(6):381–6.CrossRefGoogle Scholar
  126. 126.
    Breivik H, Borchgrevink PC, Allen SM, Rosseland LA, Romundstad L, Breivik Hals EK, et al. Assessment of pain. Br J Anaesth. 2008;101(1):17–24.PubMedCrossRefGoogle Scholar
  127. 127.
    Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer. 1981;47(1):207–14.PubMedCrossRefGoogle Scholar
  128. 128.
    Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–55.PubMedCrossRefGoogle Scholar
  129. 129.
    Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. 2003;13(3):176–81.CrossRefPubMedGoogle Scholar
  130. 130.
    Pavy JJ, Denekamp J, Letschert J, Littbrand B, Mornex F, Bernier J, et al. EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale. Int J Radiat Oncol Biol Phys. 1995;31(5):1043–7.PubMedCrossRefGoogle Scholar
  131. 131.
    Drackley NL, Degnim AC, Jakub JW, Cutshall SM, Thomley BS, Brodt JK, et al. Effect of massage therapy for postsurgical mastectomy recipients. Clin J Oncol Nurs. 2012;16(2):121–4.PubMedCrossRefGoogle Scholar
  132. 132.
    Pruthi S, Degnim AC, Bauer BA, DePompolo RW, Nayar V. Value of massage therapy for patients in a breast clinic. Clin J Oncol Nurs. 2009;13(4):422–5.PubMedCrossRefGoogle Scholar
  133. 133.
    Warpenburg MJ. Deep friction massage in treatment of radiation-induced fibrosis: rehabilitative care for breast cancer survivors. Integr Med Clin J. 2014;13(5):32–6.Google Scholar
  134. 134.
    Coyne PJ, Wan W, Dodson P, Swainey C, Smith TJ. A trial of scrambler therapy in the treatment of cancer pain syndromes and chronic chemotherapy-induced peripheral neuropathy. J Pain Palliat Care Pharmacother. 2013;27(4):359–64.PubMedPubMedCentralCrossRefGoogle Scholar
  135. 135.
    Smith T, Cheville AL, Loprinzi CL, Longo-Schoberlein D. Scrambler therapy for the treatment of chronic post-mastectomy pain (cPMP). Cureus. 2017;9(6):e1378.PubMedPubMedCentralGoogle Scholar
  136. 136.
    Bareh S, D’Silva F. Effect of music therapy on pain and quality of life among cancer survivors. Nitte Univ J Health Sci. 2017;7(3):25–9.Google Scholar
  137. 137.
    Huang S-T, Good M, Zauszniewski JA. The effectiveness of music in relieving pain in cancer patients: a randomized controlled trial. Int J Nurs Stud. 2010;47(11):1354–62.PubMedCrossRefGoogle Scholar
  138. 138.
    Li XM, Yan H, Zhou KN, Dang SN, Wang DL, Zhang YP. Effects of music therapy on pain among female breast cancer patients after radical mastectomy: results from a randomized controlled trial. Breast Cancer Res Treat. 2011;128(2):411–9.PubMedCrossRefGoogle Scholar
  139. 139.
    Bradt J, Dileo C, Magill L, Teague A. Music interventions for improving psychological and physical outcomes in cancer patients. Cochrane Database Syst Rev. 2016;8:CD006911.  https://doi.org/10.1002/14651858.CD006911.pub3.
  140. 140.
    Korhan EA, Uyar M, Eyigör C, Hakverdioğlu Yönt G, Çelik S, Khorshıd L. The effects of music therapy on pain in patients with neuropathic pain. Pain Manag Nurs. 2014;15(1):306–14.PubMedCrossRefGoogle Scholar
  141. 141.
    Stanczyk MM. Music therapy in supportive cancer care. Rep Pract Oncol Radiother. 2011;16(5):170–2.PubMedPubMedCentralCrossRefGoogle Scholar
  142. 142.
    Lawn S, Zrim S, Leggett S, Miller M, Woodman R, Jones L, et al. Is self-management feasible and acceptable for addressing nutrition and physical activity needs of cancer survivors? Health Expect Int J Publ Particip Health Care Health Policy. 2015;18(6):3358–73.Google Scholar
  143. 143.
    McCorkle R, Ercolano E, Lazenby M, Schulman-Green D, Schilling LS, Lorig K, et al. Self-management: enabling and empowering patients living with cancer as a chronic illness. CA Cancer J Clin. 2011;61(1):50–62.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Health Sciences, College of Health Professions and Sciences, Academic Health Sciences CenterUniversity of Central FloridaOrlandoUSA
  2. 2.Department of Public Health SciencesUniversity of Miami School of MedicineMiamiUSA

Personalised recommendations